Understanding T-cell Responses in Genital Herpes
Author Information
Author(s): Ralph P. Braun, Lendon G. Payne, Lichun Dong
Primary Institution: Wyeth Vaccine Research
Hypothesis
Can the IFN-γ ELISPOT assay effectively measure T-cell responses to HSV-2 antigens in patients with genital herpes?
Conclusion
The study found that CD4 T-cell responses to the immediate early antigen ICP4 were stronger in individuals with a low rate of genital herpes recurrence.
Supporting Evidence
- CD4 responses were found to have a broad specificity with positive responses to multiple antigens in all patients.
- CD8 responses were narrow and focused on small numbers of antigens.
- Stronger CD4 responses to ICP4 were present in individuals with less severe disease.
Takeaway
This study looked at how the immune system responds to genital herpes and found that some people have stronger responses that help them get fewer outbreaks.
Methodology
The IFN-γ ELISPOT assay was used to measure CD4 and CD8 T-cell responses to HSV-2 antigens in peripheral blood mononuclear cells from patients.
Limitations
The study did not perform HLA typing, which limits the ability to define specific epitopes in positive peptides.
Participant Demographics
The study included 18 individuals with genital herpes, varying in sex and age, and included both HSV-1 and HSV-2 serostatus.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website